Zobrazeno 1 - 10
of 12
pro vyhledávání: '"P. D. Ragonesi"'
Autor:
Angela D'Angelo, Natale Daniele Brunetti, P. D. Ragonesi, Mara Gavazzoni, A Maggi, Pamela Maffioli, Giovanni Gaudio, R Raddino, L. De Gennaro, Organon Investigator, M Cattaneo, Giuseppe Derosa, G Pasini
Publikováno v:
European Heart Journal. 39
Autor:
Ivano Franzetti, G Gadaleta, Ilaria Ferrari, P. D. Ragonesi, Giuseppe Derosa, M. N. Piccinni, Angela D'Angelo, Roberto Mereu, Fabrizio Querci, S. A. T. Salvadeo, Leonardina Ciccarelli, Pamela Maffioli
Publikováno v:
Hormone and Metabolic Research. 42:663-669
The aim of the study was to compare the effects of vildagliptin added to pioglitazone or glimepiride on metabolic and insulin resistance related-indices in poorly controlled type 2 diabetic patients (T2DM). 168 patients with T2DM were randomized to t
Autor:
M. N. Piccinni, Ilaria Ferrari, S. Paniga, Angela D'Angelo, Giuseppe Derosa, Leonardina Ciccarelli, S. A. T. Salvadeo, Fabio Pricolo, Lorenza Montagna, Alessia Gravina, P. D. Ragonesi, Arrigo F G Cicero
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 31:375-383
Summary Background and objective: Metformin is considered the gold standard for type 2 diabetes treatment as monotherapy and in combination with sulphonylureas and insulin. The combination of metformin with thiazolidinediones is less well studied. Th
Autor:
Fabrizio Querci, Ivano Franzetti, Angela D'Angelo, P. D. Ragonesi, Pamela Maffioli, Giuseppe Derosa
Publikováno v:
Journal of Hypertension. 33:e458-e459
Autor:
G. Derosa, P. Maffioli, S. A. Salvadeo, I. Ferrari, P. D. Ragonesi, F. Querci, I. G. Franzetti, G. Gadaleta, L. Ciccarelli, M. N. Piccinni, A. D'Angelo, CICERO, ARRIGO FRANCESCO GIUSEPPE
The aim of the study was to compare the effects of the addition of sitagliptin or metformin to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients on body weight, glycemic control, beta-cell function, insulin resistance, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4094::1fb472b0f6632e1f97f698ef737cdfae
http://hdl.handle.net/11585/104731
http://hdl.handle.net/11585/104731
Autor:
G Gadaleta, M. N. Piccinni, Giuseppe Derosa, Pamela Maffioli, Ilaria Ferrari, P. D. Ragonesi, Fabrizio Querci, S. A. T. Salvadeo, Ivano Franzetti, Arrigo F G Cicero, Leonardina Ciccarelli, Angela D'Angelo
BACKGROUND: Incretin-based therapies have provided additional options for the treatment of type 2 diabetes mellitus. The aim of our study was to evaluate the effects of exenatide compared to glibenclamide on body weight, glycemic control, beta-cell f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e80c1affc7f40279f230c22f848e0b38
http://hdl.handle.net/11585/104113
http://hdl.handle.net/11585/104113
Autor:
M. N. Piccinni, Leonardina Ciccarelli, P. D. Ragonesi, Giuseppe Derosa, Angela D'Angelo, Arrigo F G Cicero, G Gadaleta, Ivano Franzetti, Filippo Scalise
Summary Background and objective: One of the problems associated with reaching the low-density lipoprotein cholesterol (LDL-C) target during statin treatment is the emergence of laboratory or clinical side effects. The aim of our study was to evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72c603291ad5fce3d927dc724f7895eb
http://hdl.handle.net/11585/104868
http://hdl.handle.net/11585/104868
Autor:
S. Paniga, L. Ciccarelli, Angela D'Angelo, I. Ferrari, P. D. Ragonesi, M. N. Piccinni, A. Gravina, Arrigo F G Cicero, S. A. T. Salvadeo, F. Pricolo, L. Montagna, Giuseppe Derosa
Publikováno v:
Internal medicine journal. 37(2)
Background: Metformin is considered the gold standard for type 2 diabetes treatment as monotherapy and in combination with sulphonylureas and insulin, whereas the combination of metformin with thiazolidinediones is relatively less studied. The aim of
Autor:
Raffaella Fassi, Roberto Fogari, Ilaria Ferrari, Angela D'Angelo, Elena Fogari, S. A. T. Salvadeo, Giuseppe Derosa, P. D. Ragonesi, Alessia Gravina, Arrigo F G Cicero
Summary Background and objective: Angiotensin II receptor blockers represent a class of effective and well-tolerated orally active antihypertensive drugs in the general hypertensive population and in diabetic patients. The aim of our study was to inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1382f599831146c21d444793b597e406
http://hdl.handle.net/11585/106003
http://hdl.handle.net/11585/106003
Autor:
Angela D'Angelo, Pamela Maffioli, Ivano Franzetti, Fabrizio Querci, P. D. Ragonesi, Giuseppe Derosa
Publikováno v:
Journal of the American Society of Hypertension. 9:e20